Browse studies

Find your next paid study

1 recruiting study matching your filters

A Phase 2 Study to Evaluate Safety, Tolerability, And Virologic Efficacy of ARN-75039 For the Treatment of Lassa Fever in West Africa

This multicenter, randomized, open-label Phase 2 clinical trial evaluates the safety, tolerability, and virologic efficacy of ARN-75039, a novel oral antiviral…

Lassa Fever

Arisan Therapeutics, Inc.NCT07419373